1. Section Editor(s): Hess, Cathy Thomas BSN, RN, CWOCN

Article Content


Kinetic Concepts, Inc, San Antonio, TX, has received the American Podiatric Medical Association's (APMA) Seal of Approval for its V.A.C. GranuFoam Heel Dressing. The APMA conducts a rigorous product review, focusing on research, patents, quality control, proven product safety, and efficacy.


The V.A.C. GranuFoam Heel Dressing, intended for advanced wound healing, is designed to fit the contours of the heel to aid in the treatment of chronic and difficult-to-treat wounds. GranuFoam's open pore surface allows for granulation of tissue as well as exudate removal. In addition, a T.R.A.C. Pad bridge at the top of the foot provides greater patient mobility, comfort, and faster dressing changes.




Smith & Nephew Wound Management, Largo, FL, announced that GLADASE, the company's papain-urea debriding ointment, is now available for use with patients covered by Medicaid in all 50 states. GLADASE uses papain, a proteolytic enzyme derived from papaya, and urea, a denaturant of proteins, to remove necrotic tissue and liquefy slough in acute wounds, chronic wounds, infected wounds, carbuncles, and burns, and to contribute to the healing process.

FIGURE. No caption a... - Click to enlarge in new windowFIGURE. No caption available.



DermaRite Industries, Paterson, NJ, has added DermaLevin, an adhesive, waterproof foam dressing, to its line of wound care products. Designed to manage chronic and acute wounds, DermaLevin maintains a moist wound environment and absorbs 4 times more exudate than hydrocolloids, according to the manufacturer. The dressing's semipermeable film resists adherence to the wound bed and stays in place longer, reducing the frequency of dressing changes.


DermaLevin dressings are available in 2 sizes (4"x 4" and 6"x 6") and are intended for low to moderately exuding wounds; partial- and full-thickness wounds; Stages II, III, and IV pressure ulcers; and lower extremity ulcers.





LAM Pharmaceutical, Corp, Lewiston, NY, has accelerated its product launch for the LAM IPM Wound Gel in Costa Rica, Ecuador, and Panama. LAM is coordinating the launch with its Central American distributor, aQva Pharmaceuticals, Inc, which provides LAM with fully integrated regulatory, marketing, and distribution services in the Latin American market. Product demand in these 3 countries is estimated to reach 5000 to 10,000 units per month within 6 months of the product launch, according to LAM.




Molnlycke Health Care, Inc, Newtown, PA, has been awarded a 3-year contract by MedAssets HSCA, St. Louis, MO, for its Tendra wound management products, featuring Safetac technology. The products will be placed into a new dressing category termed "soft silicone dressings." Safetec is a patented soft silicone adhesive technology designed specifically for wound management dressings. Products in the Safetec line can be used on numerous wound types, including skin tears, venous leg ulcers, pressure ulcers, burns, radiation therapy skin reactions, cancer wounds, and scar management.




Diane L. Krasner, PhD, RN, CWOCN, CWS, FAAN, has been named clinical manager of the Wound Healing Center at York Hospital in York, PA. The center is a partnership between York Hospital and National Healing Corporation. Among currently held positions, Dr Krasner serves as a member of the board of directors of the American Academy of Wound Management and the National Pressure Ulcer Advisory Panel. She is a board-certified wound, ostomy, and continence nurse, a Diplomat of the American Academy of Wound Management, and a Fellow of the American Academy of Nursing.